Carregant...
Discovery of novel allosteric Eg5 inhibitors through structure-based virtual screening
Mitotic kinesin Eg5 is an attractive anti-cancer drug target. Discovery of Eg5 inhibitors has been focused on targeting the “monastrol-binding site”. However, acquired drug resistance has been reported for such inhibitors. Therefore, identifying new Eg5 inhibitors which function through a different...
Guardat en:
| Publicat a: | Chem Biol Drug Des |
|---|---|
| Autors principals: | , , , , , |
| Format: | Artigo |
| Idioma: | Inglês |
| Publicat: |
2016
|
| Matèries: | |
| Accés en línia: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4936947/ https://ncbi.nlm.nih.gov/pubmed/26864917 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1111/cbdd.12744 |
| Etiquetes: |
Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!
|